Harbir Singh Kohli

5.0k total citations
230 papers, 3.3k citations indexed

About

Harbir Singh Kohli is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Harbir Singh Kohli has authored 230 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Nephrology, 43 papers in Pulmonary and Respiratory Medicine and 42 papers in Epidemiology. Recurrent topics in Harbir Singh Kohli's work include Renal Diseases and Glomerulopathies (57 papers), Renal Transplantation Outcomes and Treatments (28 papers) and Vasculitis and related conditions (24 papers). Harbir Singh Kohli is often cited by papers focused on Renal Diseases and Glomerulopathies (57 papers), Renal Transplantation Outcomes and Treatments (28 papers) and Vasculitis and related conditions (24 papers). Harbir Singh Kohli collaborates with scholars based in India, United Kingdom and United States. Harbir Singh Kohli's co-authors include Vivekanand Jha, Kamal Sud, Krishan Lal Gupta, Vinay Sakhuja, Raja Ramachandran, V. Sakhuja, Manish Rathi, Ritambhra Nada, Kusum Joshi and Madhu Khullar and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Harbir Singh Kohli

206 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harbir Singh Kohli India 30 1.5k 607 504 419 409 230 3.3k
Elisabeth M Hodson Australia 42 1.7k 1.2× 626 1.0× 1.4k 2.8× 416 1.0× 433 1.1× 106 4.5k
Vinay Sakhuja India 23 1.2k 0.8× 429 0.7× 566 1.1× 255 0.6× 343 0.8× 90 2.5k
Krishan Lal Gupta India 23 1.0k 0.7× 409 0.7× 386 0.8× 377 0.9× 191 0.5× 111 2.1k
Bruno Ranchin France 30 1.4k 1.0× 548 0.9× 234 0.5× 328 0.8× 425 1.0× 148 3.2k
Kamal Sud Australia 26 1.3k 0.9× 340 0.6× 381 0.8× 148 0.4× 377 0.9× 143 2.6k
Lars Pape Germany 32 960 0.7× 444 0.7× 432 0.9× 352 0.8× 768 1.9× 216 3.9k
Ravi Sarode United States 43 1.3k 0.9× 496 0.8× 859 1.7× 150 0.4× 1.2k 3.0× 221 8.3k
Vincent Esnault France 33 1.6k 1.1× 1.6k 2.7× 237 0.5× 454 1.1× 320 0.8× 112 3.7k
Chiu‐Ching Huang Taiwan 30 1.2k 0.8× 499 0.8× 773 1.5× 142 0.3× 667 1.6× 147 3.3k
Jérôme Harambat France 31 1.2k 0.8× 1.1k 1.8× 277 0.5× 466 1.1× 462 1.1× 125 3.6k

Countries citing papers authored by Harbir Singh Kohli

Since Specialization
Citations

This map shows the geographic impact of Harbir Singh Kohli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harbir Singh Kohli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harbir Singh Kohli more than expected).

Fields of papers citing papers by Harbir Singh Kohli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harbir Singh Kohli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harbir Singh Kohli. The network helps show where Harbir Singh Kohli may publish in the future.

Co-authorship network of co-authors of Harbir Singh Kohli

This figure shows the co-authorship network connecting the top 25 collaborators of Harbir Singh Kohli. A scholar is included among the top collaborators of Harbir Singh Kohli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harbir Singh Kohli. Harbir Singh Kohli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
C.W., Ronald, et al.. (2025). WCN25-3605 Transplant immunosuppressant: a double edged sword in a kidney transplant patient. Kidney International Reports. 10(2). S532–S532.
2.
Pal, Deeksha, Manphool Singhal, Anupam Lal, et al.. (2024). Augmented mannose‐binding lectin levels in primary membranous nephropathy: A pilot study. Nephrology. 29(9). 617–621.
3.
Kohli, Harbir Singh, et al.. (2023). Niacinamide and Renal Recovery After AKI: A Randomized, Controlled Trial. Journal of the American Society of Nephrology. 34(11S). 60–60. 2 indexed citations
4.
Pal, Deeksha, Vinod Kumar, Ashwini Kumar, et al.. (2023). Rituximab in Patients With Primary Membranous Nephropathy With High Immunologic Risk. Kidney International Reports. 8(8). 1660–1664. 3 indexed citations
5.
6.
Bharati, Joyita, Pandiarajan Vignesh, Kenar D. Jhaveri, et al.. (2023). Memory B cells predict outcome in primary podocytopathies of adults. Nephrology Dialysis Transplantation. 38(12). 2854–2857. 1 indexed citations
7.
Naidu, GSRSNK, Aman Sharma, Alok Sharma, et al.. (2022). ANCA-associated vasculitis following ChAdOx1 nCoV19 vaccination: case-based review. Rheumatology International. 42(4). 749–758. 48 indexed citations
8.
Ramachandran, Raja, Vinod Kumar, Vinod Kumar, et al.. (2020). Primary membranous nephropathy in children and adolescents: a single-centre report from South Asia. Pediatric Nephrology. 36(5). 1217–1226. 5 indexed citations
9.
10.
Bansal, Akash, Ashok Kumar Yadav, Pankaj Bahuguna, et al.. (2019). Reversal of endothelial dysfunction post-immunosuppressive therapy in adult-onset podocytopathy and primary membranous nephropathy. Atherosclerosis. 295. 38–44. 6 indexed citations
11.
Ramachandran, Raja, Joyita Bharati, Indu Ramachandra Rao, et al.. (2018). Persistent CD‐19 depletion by rituximab is cost‐effective in maintaining remission in calcineurin‐inhibitor dependent podocytopathy. Nephrology. 24(12). 1241–1247. 15 indexed citations
12.
Naidu, GSRSNK, Aman Sharma, Ritambhra Nada, et al.. (2014). Histopathological classification of pauci-immune glomerulonephritis and its impact on outcome. Rheumatology International. 34(12). 1721–1727. 22 indexed citations
13.
Kumar, Vivek, Ritambhra Nada, Raja Ramachandran, et al.. (2012). Acute Kidney Injury Due to Acute Cortical Necrosis Following a Single Wasp Sting. Renal Failure. 35(1). 170–172. 22 indexed citations
14.
Chopra, Seema, et al.. (2008). Pregnancy in chronic renal insufficiency: single centre experience from North India. Archives of Gynecology and Obstetrics. 279(5). 691–695. 13 indexed citations
15.
Ahluwalia, Tarunveer S., Monica Ahuja, Taranjit Singh, et al.. (2008). ACE Variants Interact with the RAS Pathway to Confer Risk and Protection against Type 2 Diabetic Nephropathy. DNA and Cell Biology. 28(3). 141–150. 56 indexed citations
16.
Poduri, Aruna, Debabrata Mukherjee, Kamal Sud, et al.. (2007). MTHFR A1298C polymorphism is associated with cardiovascular risk in end stage renal disease in North Indians. Molecular and Cellular Biochemistry. 308(1-2). 43–50. 22 indexed citations
17.
Singh, Vijender, et al.. (2002). Postrenal transplant erythrocytosis: risk factors and effectiveness of angiotensin receptor antagonists. Transplantation Proceedings. 34(8). 3191–3192. 3 indexed citations
18.
Kohli, Harbir Singh, et al.. (2002). Visceral leishmaniasis: a rare cause of post-transplant fever and pancytopenia.. PubMed. 50. 979–80. 7 indexed citations
19.
Jha, Vivekanand, Thangamani Muthukumar, Harbir Singh Kohli, et al.. (2001). Impact of cyclosporine withdrawal on living related renal transplants: A single-center experience. American Journal of Kidney Diseases. 37(1). 119–124. 14 indexed citations
20.
Jha, Vivekanand, M. Satya Murthy, Harbir Singh Kohli, et al.. (1998). Secondary Membranoproliferative Glomerulonephritis Due to Hemolytic Uremic Syndrome: An Unusual Presentation. Renal Failure. 20(6). 845–850. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elisabeth M Hodson Breakdown of academic impact, for papers by Vinay Sakhuja Breakdown of academic impact, for papers by Krishan Lal Gupta Breakdown of academic impact, for papers by Bruno Ranchin Breakdown of academic impact, for papers by Kamal Sud Breakdown of academic impact, for papers by Lars Pape Breakdown of academic impact, for papers by Ravi Sarode Breakdown of academic impact, for papers by Vincent Esnault Breakdown of academic impact, for papers by Chiu‐Ching Huang Breakdown of academic impact, for papers by Jérôme Harambat
Rankless by CCL
2026